Search Results - "Pai, Manjunath P"

Refine Results
  1. 1

    Reappraisal of Linezolid Dosing in Renal Impairment To Improve Safety by Crass, Ryan L, Cojutti, Pier Giorgio, Pai, Manjunath P, Pea, Federico

    Published in Antimicrobial agents and chemotherapy (01-08-2019)
    “…Linezolid is administered as a fixed dose to all patients despite evidence of increased exposure and myelosuppression in renal impairment. The objectives of…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Innovative approaches to optimizing the delivery of vancomycin in individual patients by Pai, Manjunath P., Neely, Michael, Rodvold, Keith A., Lodise, Thomas P.

    Published in Advanced drug delivery reviews (20-11-2014)
    “…The delivery of personalized antimicrobial therapy is a critical component in the treatment of patients with invasive infections. Vancomycin, the drug of…”
    Get full text
    Journal Article
  4. 4

    Pharmacokinetics of Tedizolid in Morbidly Obese and Covariate-Matched Nonobese Adults by Pai, Manjunath P

    Published in Antimicrobial agents and chemotherapy (01-08-2016)
    “…Tedizolid is a novel oxazolidinone antimicrobial administered in its prodrug form, tedizolid phosphate, as a fixed once-daily dose. The pharmacokinetics of…”
    Get full text
    Journal Article
  5. 5

    Population Pharmacokinetics and Dosing Considerations for the Use of Linezolid in Overweight and Obese Adult Patients by Cojutti, Piergiorgio, Pai, Manjunath P., Pea, Federico

    Published in Clinical pharmacokinetics (01-08-2018)
    “…Background Linezolid is an anti-Gram-positive antimicrobial agent used at a fixed dose of 600 mg every 12 h. Objectives The objective of this study was to…”
    Get full text
    Journal Article
  6. 6

    Volumetric Absorptive Microsampling to Enhance the Therapeutic Drug Monitoring of Tacrolimus and Mycophenolic Acid: A Systematic Review and Critical Assessment by Leino, Abbie D., Takyi-Williams, John, Pai, Manjunath P.

    Published in Therapeutic drug monitoring (01-08-2023)
    “…Volumetric absorptive microsampling (VAMS) is an emerging technique that may support multisample collection to enhance therapeutic drug monitoring in solid…”
    Get full text
    Journal Article
  7. 7

    Reconsideration of the current models of estimated kidney function-based drug dose adjustment in older adults: The role of biological age by Alikhani, Radin, Pai, Manjunath P

    Published in Clinical and translational science (01-11-2023)
    “…Human lifespan has increased from a median of 46.5 years in 1950 to 71.7 years in 2022. As people age, one of the inevitable consequences is a decline in…”
    Get full text
    Journal Article
  8. 8

    Time to Initiation of Fluconazole Therapy Impacts Mortality in Patients with Candidemia: A Multi-Institutional Study by Garey, Kevin W., Rege, Milind, Pai, Manjunath P., Mingo, Dana E., Suda, Katie J., Turpin, Robin S., Bearden, David T.

    Published in Clinical infectious diseases (01-07-2006)
    “…Background. Inadequate antimicrobial treatment is an independent determinant of hospital mortality, and fungal bloodstream infections are among the types of…”
    Get full text
    Journal Article
  9. 9

    Estimated glomerular filtration rate with and without race for drug dosing: Cystatin C vs. serum creatinine by Yun, Hyun Gi, Smith, Andrew J. F., DeBacker, Kenneth C., Pai, Manjunath P.

    Published in British journal of clinical pharmacology (01-03-2023)
    “…The goal of this study was to use a model kidney function clearance‐dependent drug (vancomycin) to understand the gain or loss of precision in dosing with use…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Panobinostat penetrates the blood–brain barrier and achieves effective brain concentrations in a murine model by Homan, Morgan J., Franson, Andrea, Ravi, Karthik, Roberts, Holly, Pai, Manjunath P., Liu, Cai, He, Miao, Matvekas, Aleksas, Koschmann, Carl, Marini, Bernard L.

    Published in Cancer chemotherapy and pharmacology (01-09-2021)
    “…Purpose Panobinostat, an orally bioavailable pan-HDAC inhibitor, has demonstrated potent activity in multiple malignancies, including pediatric brain tumors…”
    Get full text
    Journal Article
  12. 12

    Individualized Vancomycin Dosing in Obese Patients: A Two-Sample Measurement Approach Improves Target Attainment by Hong, Joseph, Krop, Lynne C., Johns, Tracy, Pai, Manjunath P.

    Published in Pharmacotherapy (01-05-2015)
    “…Study Objective To compare the likelihood of vancomycin target trough concentration attainment based on infectious diagnosis and/or minimum inhibitory…”
    Get full text
    Journal Article
  13. 13

    Paclitaxel Plasma Concentration after the First Infusion Predicts Treatment-Limiting Peripheral Neuropathy by Hertz, Daniel L, Kidwell, Kelley M, Vangipuram, Kiran, Li, Feng, Pai, Manjunath P, Burness, Monika, Griggs, Jennifer J, Schott, Anne F, Van Poznak, Catherine, Hayes, Daniel F, Lavoie Smith, Ellen M, Henry, N Lynn

    Published in Clinical cancer research (01-08-2018)
    “…Paclitaxel exposure, specifically the maximum concentration ( ) and amount of time the concentration remains above 0.05 μmol/L ( ), has been associated with…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Estimation of creatinine clearance in morbidly obese patients by Demirovic, Jasmina A, Pai, Amy Barton, Pai, Manjunath P

    Published in American journal of health-system pharmacy (01-04-2009)
    “…Estimates of creatinine clearance (CL(cr)) based on equations and various body-size descriptors were compared with 24-hour measured CL(cr) values in morbidly…”
    Get full text
    Journal Article
  16. 16

    Steady-State Plasma Pharmacokinetics of Oral Voriconazole in Obese Adults by PAI, Manjunath P, LODISE, Thomas P

    Published in Antimicrobial Agents and Chemotherapy (01-06-2011)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  17. 17

    Characterization of genetic changes associated with daptomycin nonsusceptibility in Staphylococcus aureus by Ma, Zhuo, Lasek-Nesselquist, Erica, Lu, Jackson, Schneider, Ryan, Shah, Riddhi, Oliva, George, Pata, Janice, McDonough, Kathleen, Pai, Manjunath P, Rose, Warren E, Sakoulas, George, Malik, Meenakshi

    Published in PloS one (07-06-2018)
    “…The extensive use of daptomycin (DAP) for treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the last decade has led to the…”
    Get full text
    Journal Article
  18. 18

    Simplified Estimation of Aminoglycoside Pharmacokinetics in Underweight and Obese Adult Patients by PAI, Manjunath P, NAFZIGER, Anne N, BERTINO, Joseph S

    Published in Antimicrobial Agents and Chemotherapy (01-09-2011)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  19. 19

    Use of Oral Tetracyclines in the Treatment of Adult Patients with Community-Acquired Bacterial Pneumonia: A Literature Review on the Often-Overlooked Antibiotic Class by Bidell, Monique R, Pai, Manjunath Amit P, Lodise, Thomas P

    Published in Antibiotics (Basel) (14-12-2020)
    “…Oral tetracyclines have been used in clinical practice for over 60 years. Overall, one of the most common indications for use of oral tetracyclines is for…”
    Get full text
    Journal Article
  20. 20

    Association of Fluconazole Area under the Concentration-Time Curve/MIC and Dose/MIC Ratios with Mortality in Nonneutropenic Patients with Candidemia by PAI, Manjunath P, TURPIN, Robin S, GAREY, Kevin W

    Published in Antimicrobial Agents and Chemotherapy (01-01-2007)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article